NCT05704985
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05704985
Title Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors DEKA Biosciences
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Northwell Health Manhasset New York 11030 United States Details
OU Health Stephenson Cancer Center Oklahoma City Oklahoma 73104 United States Details
Mary Crowley Cancer Research Dallas Texas 75230 United States Details
University of Texas Southwestern Dallas Texas 75390 United States Details
The University of Texas M.D. Anderson Cancer Center Houston Texas 77030 United States Details
NEXT Oncology Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field